Quality of Life After Cosmetic Treatments
ConditionCosmetic Treatment Wish
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
About this trial
Prospective cohort study, investigating the pre-post treatment effect of cosmetic injectable and surgical treatments on quality of life (primary outcome measure: FACE-Q Psychological, secondary outcome measure: FACE-Q Social), compared with a non-treated control group. Propensity score analysis is used to reduce confounding by indication.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Clients who have booked a cosmetic treatment (injectables or surgery) in one of the contributing clinics in the Netherlands
Disqualifiers
Regular contra-indications as per clinic protocol / physician judgment
Trial population
Clients seeking cosmetic treatments, who have already booked an appointment for consultation and/or treatment at a Dutch clinic.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
1,080 Participants
are grouped into 13 trial groups13
Trial groupsSee each trial group below.
Group A: botulinum toxin, glabella/frown
Group B: botulinum toxin, crow's feet
Group C: botulinum toxin, forehead
Group D: botulinum toxin, masseters
Group E: hyaluronic acid filler, lips
Group F: hyaluronic acid filler, zygoma
Group G: hyaluronic acid filler, jawline and/or chin
Group H: hyaluronic acid filler, marionet lines and/or nasolabial
Group I: surgery, upper blepharoplasty
Group J: surgery, labiaplasty
Group K: surgery, breast augmentation
Group L: surgery, liposuction
Group M: Untreated controls
Trial outcomes
Primary outcomes
1
FACE-Q Psychological Wellbeing
Change in score from baseline to follow-up
Time frame
Botulinum neurtoxin type A: From baseline to 2-months follow-up Hyaluronic acid dermal fillers: From baseline to 3-months follow-up Surgery: From baseline to 12-months follow-upSecondary outcomes
1
FACE-Q Social function
Change in score from baseline to follow-up
Time frame
Botulinum neurtoxin type A: From baseline to 2-months follow-up Hyaluronic acid dermal fillers: From baseline to 3-months follow-up Surgery: From baseline to 12-months follow-upLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: